Home » Healthcare » BCG Vaccine Market

BCG Vaccine Market By Age Group (Paediatrics and Adults) By Application (Tuberculosis and Bladder Cancer) By Distribution Channel (Hospitals, Clinics, and Other Distribution Channels)-Growth, Future Prospects & Competitive Analysis, 2016 – 2030

Summary
Table Of Content

Key Highlights of the report

How are the prominent segments performing in the BCG Vaccine market?

In 2022, the pediatric segment accounted for the largest market share due to the growing prevalence of childhood tuberculosis.
In 2022, the hospital segment was anticipated to hold a major share of the global BCG vaccine market due to rising procurement and availability of vaccines in hospital settings.
In 2022, the tuberculosis segment was anticipated to hold a prominent share of the global BCG vaccine market due to the rapidly rising incidence of tuberculosis.

What is the Market Size of BCG Vaccine regarding value?

The global BCG vaccine market is anticipated to grow at a substantial CAGR of 5.50% in the upcoming years. The global BCG vaccine industry was estimated to be worth USD 46.5 billion in 2022 and was expected to be worth USD 67.64 billion by 2028.

Which region dominated the BCG vaccine market?

In 2022, the Asia Pacific region was anticipated to hold a major share of the global BCG vaccine market. This is due to the rising prevalence of tuberculosis in developing countries like India, Indonesia, and China is the main reason for the growth of the Asia-Pacific region. For instance, according to an article titled “Pediatric Tuberculosis with a Focus on Indonesia, “published by United Nations International Children’s Emergency Fund (UNICEF) in June 2022, Indonesia has the second highest incidence of TB in the world (rate of 312 per 100,000 population) and accounts for 8.5 percent of global cases.

Access crucial information at unmatched prices!

Request your free sample report today & start making informed decisions powered by Credence Research!

Download Free Sample

How is US Market performing in the BCG vaccine market?

In 2022, the US BCG vaccine market will grow over the forecast period owing to government policies and an increased focus on immunization programs. Moreover, the prevalence of bladder cancer is growing in this region, increasing demand for the BCG vaccine in treating bladder cancer. As per the Centers for Disease Control and Prevention, bladder cancer affects about 57,000 men and 18,000 women in the U.S. annually, with around 12,000 men and 5,000 women dying from the disease.

How is the economy impacting the global BCG vaccine growth?

Looking at the economic benefits of the market, a 50% effective vaccine could save US$ 36.6–41.5 billion in TB-related household expenditure, which assists in averting two-thirds of catastrophic prices incurred by many people in the bottom wealth quintile. The same vaccine may provide gains in gross domestic vaccines of US$ 1.6 trillion between 2025 and 2080.

What is the competitive environment of the BCG vaccine market?

The BCG vaccine industry’s competitive environment delivers information on the whole economic profit made by suppliers and businesses, the sales and profits created in this sector, the BCG Vaccine market share worldwide, the business firms summary, the introduction of new products, and the opportunities for the industrial BCG Vaccine market. For instance, in March 2022, the company named Serum Institute of India Pvt. Ltd. used the Drugs Controller General of India to pursue emergency authorization for its recombinant BCG (rBCG) vaccine to prevent tuberculosis.

Executive Summary

What are the major trends in the BCG Vaccine market?

The BCG vaccine market is expanding due to increased TB cases worldwide, rapid advancements in technology in medical research on vaccines, and favorable government policies with increased funding. Several online and offline campaigns have emerged in the last few years to inform the masses about proper vaccination.
The increased prevalence of tuberculosis and increasing company initiatives to enhance vaccine R&D drive the global bacillus calmette-guerin (BCG) vaccine market.

How COVID-19 pandemic has affected the BCG vaccine market?

COVID-19 has disrupted the global economy drastically. The World Health Organization (WHO) announced COVID-19, a pandemic that has extended to about 203 countries worldwide. The lockdown has impacted several industries in various ways; some industries got affected badly, and some gained revenues. The market has seen some profits. The BCG vaccine is utilized to prevent Tuberculosis, but some researchers have declared that the BCG vaccine can be utilized for COVID treatment, fuelling the market. But the BCG vaccine was not a perfect cure for COVID; it is an immediate medication to stop deaths. All the COVID-affected more senior people got vaccinated in regions like India, which expanded the BCG vaccine market. Few regions have done clinical trials on people to see the BCG vaccine’s effectiveness, boosting the market growth. These factors assisted the BCG vaccine market in growing during the COVID-19 pandemic. The major players in the market have done a great job by growing BCG vaccine production during the pandemic.

Which are the key investments by the BCG vaccine market players?

Leading players operating in the BCG vaccine market are focusing on expanding production capacities for the vaccine. Apart from this, players are concentrating on strategic mergers, acquisitions, and market collaborations to gain a competitive edge. For instance, in March 2021, by taking the assistance of South Korea, the TB Alliance launched an initiative known as LIFT-TB. LIFT-TB stands for Leveraging Innovation for Faster Treatment of Tuberculosis. The prominent purpose of this initiative is to fasten the R&D of TB treatments by providing the required funding and other support.

Some major players in the BCG vaccine market are GreenSignal Bio Pharma Private Limited., Serum Institute of India Ltd., Merck, Co. Inc., Bharat Biotech Pvt. Ltd., Sanofi, InterVax, Shanghai Institute of Biological Products, Statens Serum Institute., and China National Biotec.

What are the prominent driving factors for the BCG vaccine market?

BCG vaccine confers broad-spectrum protection against other infectious diseases and, over the last year, has been proposed to reduce the severity of COVID-19 infection. Accessibility to the Bacillus Calmette-Guérin vaccine can help mitigate the impact of the pandemic in several countries. It offers significant advantages and flexibility in the way clinical vaccines are administered. Clinical laboratories across the globe have been exploring the possibility that the BCG vaccine can be used alone or synergistically to reduce the severity of COVID-19 infections owing to its enhanced protective response against viral respiratory diseases. Certain research studies suggest immunization with recombinant BCG vaccine protects against respiratory syncytial virus-associated lung damage, reduces infiltration of inflammatory immune cells into the lungs, and reduces the viral load in lung tissues. This evidence has further highlighted the possibility that mucosal administration of BCG that stimulates trained memory can lead to a more effective innate immune response in the lungs of COVID-19 patients.

What are the major risks for the BCG vaccine market?

Increasing problems with vaccine production and limited supplier options in various developing and underdeveloped countries have drastically affected BCG vaccines’ global availability and procurement. Inaccessibility and shortage of BCG vaccine are also increasing concerns regarding a substantial increase in childhood mortality across the globe. Disruptions to the vaccine supply chain can severely affect BCG’s health system delivery. In addition, problems with manufacturing processes, modification of quality control processes, and scarcity and inaccessibility of raw materials can also hamper the vaccine supply chain. Considering the robust transmissibility of infectious diseases, vaccine shortages can impact individual and population health through the herd effect, further representing a worldwide threat.

Which is the key application in the BCG vaccine market?

The pediatric segment is expected to hold a major share of the global BCG vaccine market during the forecast period. This is due to the increasing prevalence of childhood tuberculosis, the growing focus on implementing TB control programs, and mandatory BCG vaccination of neonates and infants. Tuberculosis in children presents different challenges and has remained a heavy burden on the international public health landscape. However, research activities and advancements in pediatric TB research have provided wider insights and opportunities for TB control. This has further boosted demand for better diagnostic tools to improve individual case management, provide a more strong case definition for drug and vaccine trials, and for studies of TB epidemiology and protective immunity in childhood.

How is the BCG vaccine market performing in regions?

North America is expected to register significant revenue growth over the forecast period, attributable to increasing focus on immunization in the United States, efforts taken by government and healthcare authorities to procure and administer the vaccine, availability of cost-effective vaccine dosages and reimbursement policies, increasing initiatives to promote vaccination in the region, presence of key manufacturers, and establishment of advanced healthcare facilities. In addition, increasing investment to accelerate pediatric TB research, a growing number of clinical trials to test the efficacy of BCG vaccines in cohorts of different ethnicities, and a rising number of high-risk populations are other factors expected to drive market growth in the region.

What is the regulatory landscape for the BCG vaccine market?

Over the past decade, several countries across all regions, income groups, and procurement methods have been unable to secure sufficient BCG vaccine supply. While the frequency of stock-outs has remained rather stable, duration increased due to manufacturing issues and attracted the attention of national, regional, and global immunization stakeholders. This prompted an in-depth analysis of supply and demand dynamics to characterize supply risks.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Customize Now

What are the prominent players planning for the future of the BCG vaccine market?

Growing regional existence and investment in downstream applications are anticipated to deliver a competitive edge in the market. For instance, in January 2023, the World Health Organization (WHO) introduced TB Vaccine Accelerator Council. The prominent purpose of the council is to quicken the licensing and effectiveness of novel TB vaccines by coordinating several parties involved in the development and usage of vaccines.

REPORT ATTRIBUTE	DETAILS
BCG Vaccine Market by Volume	Yes
BCG Vaccine Market by Value	Yes
BCG Vaccine Market, Tornado Analysis	Yes
BCG Vaccine Market, STAR Analysis	Yes
BCG Vaccine Market, SRC Analysis	Yes
BCG Vaccine Market, Import-Export Data	Yes (On Demand)
BCG Vaccine Market Pricing Analysis	Yes (On Demand)
BCG Vaccine Market Segment Analysis	By Age Group (Paediatrics and Adults) By Application (Tuberculosis and Bladder Cancer) By Distribution Channel (Hospitals, Clinics, and Other Distribution Channels)
BCG Vaccine Market, Regional Analysis	North America (US and Canada) Europe (Germany, UK, France, Italy, Spain, and the Rest of Europe) Asia Pacific (China, India, Japan, South Korea, South East Asia, and the Rest of Asia Pacific) Latin America (Brazil, Mexico, and the Rest of Latin America) Middle East and Africa (GCC Countries, South Africa, and the Rest of Middle East and Africa)
BCG Vaccine Market Key Companies	GreenSignal Bio Pharma Private Limited., Serum Institute of India Ltd., Merck, Co. Inc., Bharat Biotech Pvt. Ltd., Sanofi, InterVax, Shanghai Institute of Biological Products, Statens Serum Institute., and China National Biotec
BCG Vaccine Market Competitive Landscape	Market Share Analysis Competitive Benchmarking Key Players Market Positioning Geographical Presence Analysis Major Strategies Adopted

Segmentation of Global BCG Vaccine Market-

Global BCG Vaccine Market – By Age Group

Paediatrics
Adults

Global BCG Vaccine Market – By Application

Tuberculosis
Bladder Cancer

Global BCG Vaccine Market – By Distribution Channel

Hospitals
Clinics
Other Distribution Channels

Global BCG Vaccine Market – By Region

North America
- U.S.
- Canada
Europe
- Germany
- France
- U.K.
- Italy
- Spain
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- South Korea
- South-east Asia
- Rest of Asia Pacific
Latin America
- Brazil
- Mexico
- Rest of Latin America
Middle East & Africa
- GCC Countries
- South Africa
- Rest of Middle East and Africa

1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I – Secondary Research
1.3.2. Phase II – Primary Research
1.3.3. Phase III – Expert Panel Review
1.3.4. Approach Adopted
1.3.4.1. Top-Down Approach
1.3.4.2. Bottom-Up Approach
1.3.5. Assumptions
1.4. Market Introduction
1.5. Market Research Scope

2. Executive Summary
2.1. Market Snapshot: Global BCG Vaccine Market
2.2. Global BCG Vaccine Market, By Age Group
2.3. Global BCG Vaccine Market, By Distribution Channel
2.4. Global BCG Vaccine Market, By Application
2.5. Global BCG Vaccine Market, By Region

3. Market Dynamics & Factors Analysis
3.1. Introduction
3.1.1. Global BCG Vaccine Market Value, 2017-2030, (US$ Bn)
3.1.2. Y-o-Y Growth Trend Analysis
3.2. Market Dynamics
3.2.1. Market Drivers
3.2.2. Market Restraints
3.2.3. Market Opportunities
3.2.4. Major Industry Challenges
3.3. Growth and Development Patterns
3.4. Investment Feasibility Analysis
3.5. Market Opportunity Analysis
3.5.1. Type
3.5.2. Distribution Channel
3.5.3. Application
3.5.4. Geography

4. Premium Insights
4.1. STAR (Situation, Task, Action, Results) Analysis
4.2. Porter’s Five Forces Analysis
4.2.1. Threat of New Entrants
4.2.2. Bargaining Power of Buyers/Consumers
4.2.3. Bargaining Power of Suppliers
4.2.4. Threat of Substitute Types
4.2.5. Intensity of Competitive Rivalry
4.3. Key Market Trends
4.3.1. Demand Side Trends
4.3.2. Supply Side Trends
4.4. Value Chain Analysis
4.5. Age Group Analysis
4.6. Analysis and Recommendations
4.7. Marketing Strategy Analysis
4.7.1. Direct Marketing
4.7.2. Indirect Marketing
4.7.3. Marketing Channel Development Trend

5. Market Positioning of Key Players, 2022
5.1. Company market share of key players, 2022
5.2. Competitive Benchmarking
5.3. Market Positioning of Key Vendors
5.4. Geographical Presence Analysis
5.5. Major Strategies Adopted by Key Players
5.5.1. Key Strategies Analysis
5.5.2. Mergers and Acquisitions
5.5.3. Partnerships
5.5.4. Product Launch
5.5.5. Geographical Expansion
5.5.6. Others

6. Economic Impact Analysis
6.1. Recession Impact
6.1.1. North America
6.1.2. Europe
6.1.3. Asia Pacific
6.1.4. Latin America
6.1.5. Middle East and Africa
6.2. Ukraine-Russia War Impact
6.2.1. North America
6.2.2. Europe
6.2.3. Asia Pacific
6.2.4. Latin America
6.2.5. Middle East and Africa
6.3. COVID-19 Impact Analysis
6.3.1. North America
6.3.2. Europe
6.3.3. Asia Pacific
6.3.4. Latin America
6.3.5. Middle East and Africa

7. Global BCG Vaccine Market
7.1. Global BCG Vaccine Market, by Age Group, 2017-2030 (US$ Bn)
7.1.1. Overview
7.1.2. Global BCG Vaccine Market, By Age Group, 2022 vs 2030 (in%)
7.1.3. Global BCG Vaccine Market, By Paediatrics, 2017-2030 (US$ Bn)
7.1.4. Global BCG Vaccine Market, By Adults, 2017-2030 (US$ Bn)
7.2. Global BCG Vaccine Market, by Distribution Channel, 2017-2030 (US$ Bn)
7.2.1. Overview
7.2.2. Global BCG Vaccine Market, By Distribution Channel, 2022 vs 2030 (in%)
7.2.3. Global BCG Vaccine Market, By Hospitals, 2017-2030 (US$ Bn)
7.2.4. Global BCG Vaccine Market, By Clinics, 2017-2030 (US$ Bn)
7.2.5. Global BCG Vaccine Market, By Other Distribution Channels, 2017-2030 (US$ Bn)
7.3. Global BCG Vaccine Market, by Application, 2017-2030 (US$ Bn)
7.3.1. Overview
7.3.2. Global BCG Vaccine Market, By Application, 2022 vs 2030 (in%)
7.3.3. Global BCG Vaccine Market, By Tuberculosis, 2017-2030 (US$ Bn)
7.3.4. Global BCG Vaccine Market, By Bladder Cancer, 2017-2030 (US$ Bn)

8. North America BCG Vaccine Market Analysis
8.1. North America BCG Vaccine Market, by Age Group, 2017-2030(US$ Bn)
8.1.1. Overview
8.1.2. SRC Analysis
8.2. North America BCG Vaccine Market, by Distribution Channel, 2017-2030(US$ Bn)
8.2.1. Overview
8.2.2. SRC Analysis
8.3. North America BCG Vaccine Market, by Application, 2017-2030(US$ Bn)
8.3.1. Overview
8.3.2. SRC Analysis
8.4. North America BCG Vaccine Market, by Country, 2017-2030 (US$ Bn)
8.4.1. U.S.
8.4.1.1. U.S. BCG Vaccine Market Estimates and Forecast, 2017-2030 (US$ Bn)
8.4.1.2. U.S. BCG Vaccine, By Age Group, 2017-2030 (US$ Bn)
8.4.1.3. U.S. BCG Vaccine, By Distribution Channel, 2017-2030 (US$ Bn)
8.4.1.4. U.S. BCG Vaccine, By Application, 2017-2030 (US$ Bn)
8.4.2. Canada
8.4.2.1. Canada BCG Vaccine Market Estimates and Forecast, 2017-2030 (US$ Bn)
8.4.2.2. Canada BCG Vaccine, By Age Group, 2017-2030 (US$ Bn)
8.4.2.3. Canada BCG Vaccine, By Distribution Channel, 2017-2030 (US$ Bn)
8.4.2.4. Canada BCG Vaccine, By Application, 2017-2030 (US$ Bn)

9. Europe BCG Vaccine Market Analysis
9.1. Europe BCG Vaccine Market, by Age Group, 2017-2030(US$ Bn)
9.1.1. Overview
9.1.2. SRC Analysis
9.2. Europe BCG Vaccine Market, by Distribution Channel, 2017-2030(US$ Bn)
9.2.1. Overview
9.2.2. SRC Analysis
9.3. Europe BCG Vaccine Market, by Application, 2017-2030(US$ Bn)
9.3.1. Overview
9.3.2. SRC Analysis
9.4. Europe BCG Vaccine Market, by Country, 2017-2030 (US$ Bn)
9.4.1. Germany
9.4.1.1. Germany BCG Vaccine Market Estimates and Forecast, 2017-2030 (US$ Bn)
9.4.1.2. Germany BCG Vaccine, By Age Group, 2017-2030 (US$ Bn)
9.4.1.3. Germany BCG Vaccine, By Distribution Channel, 2017-2030 (US$ Bn)
9.4.1.4. Germany BCG Vaccine, By Application, 2017-2030 (US$ Bn)
9.4.2. France
9.4.2.1. France BCG Vaccine Market Estimates and Forecast, 2017-2030 (US$ Bn)
9.4.2.2. France BCG Vaccine, By Age Group, 2017-2030 (US$ Bn)
9.4.2.3. France BCG Vaccine, By Distribution Channel, 2017-2030 (US$ Bn)
9.4.2.4. France BCG Vaccine, By Application, 2017-2030 (US$ Bn)
9.4.3. UK
9.4.3.1. UK BCG Vaccine Market Estimates and Forecast, 2017-2030 (US$ Bn)
9.4.3.2. UK BCG Vaccine, By Age Group, 2017-2030 (US$ Bn)
9.4.3.3. UK BCG Vaccine, By Distribution Channel, 2017-2030 (US$ Bn)
9.4.3.4. UK BCG Vaccine, By Application, 2017-2030 (US$ Bn)
9.4.4. Italy
9.4.4.1. Italy BCG Vaccine Market Estimates and Forecast, 2017-2030 (US$ Bn)
9.4.4.2. Italy BCG Vaccine, By Age Group, 2017-2030 (US$ Bn)
9.4.4.3. Italy BCG Vaccine, By Distribution Channel, 2017-2030 (US$ Bn)
9.4.4.4. Italy BCG Vaccine, By Application, 2017-2030 (US$ Bn)
9.4.5. Spain
9.4.5.1. Spain BCG Vaccine Market Estimates and Forecast, 2017-2030 (US$ Bn)
9.4.5.2. Spain BCG Vaccine, By Age Group, 2017-2030 (US$ Bn)
9.4.5.3. Spain BCG Vaccine, By Distribution Channel, 2017-2030 (US$ Bn)
9.4.5.4. Spain BCG Vaccine, By Application, 2017-2030 (US$ Bn)
9.4.6. Rest of Europe
9.4.6.1. Rest of Europe BCG Vaccine Market Estimates and Forecast, 2017-2030 (US$ Bn)
9.4.6.2. Rest of Europe BCG Vaccine, By Age Group, 2017-2030 (US$ Bn)
9.4.6.3. Rest of Europe BCG Vaccine, By Distribution Channel, 2017-2030 (US$ Bn)
9.4.6.4. Rest of Europe BCG Vaccine, By Application, 2017-2030 (US$ Bn)

10. Asia Pacific BCG Vaccine Market Analysis
10.1. Asia Pacific BCG Vaccine Market, by Age Group, 2017-2030(US$ Bn)
10.1.1. Overview
10.1.2. SRC Analysis
10.2. Asia Pacific BCG Vaccine Market, by Distribution Channel, 2017-2030(US$ Bn)
10.2.1. Overview
10.2.2. SRC Analysis
10.3. Asia Pacific BCG Vaccine Market, by Application, 2017-2030(US$ Bn)
10.3.1. Overview
10.3.2. SRC Analysis
10.4. Asia Pacific BCG Vaccine Market, by Country, 2017-2030 (US$ Bn)
10.4.1. China
10.4.1.1. China BCG Vaccine Market Estimates and Forecast, 2017-2030 (US$ Bn)
10.4.1.2. China BCG Vaccine, By Age Group, 2017-2030 (US$ Bn)
10.4.1.3. China BCG Vaccine, By Distribution Channel, 2017-2030 (US$ Bn)
10.4.1.4. China BCG Vaccine, By Application, 2017-2030 (US$ Bn)
10.4.2. Japan
10.4.2.1. Japan BCG Vaccine Market Estimates and Forecast, 2017-2030 (US$ Bn)
10.4.2.2. Japan BCG Vaccine, By Age Group, 2017-2030 (US$ Bn)
10.4.2.3. Japan BCG Vaccine, By Distribution Channel, 2017-2030 (US$ Bn)
10.4.2.4. Japan BCG Vaccine, By Application, 2017-2030 (US$ Bn)
10.4.3. India
10.4.3.1. India BCG Vaccine Market Estimates and Forecast, 2017-2030 (US$ Bn)
10.4.3.2. India BCG Vaccine, By Age Group, 2017-2030 (US$ Bn)
10.4.3.3. India BCG Vaccine, By Distribution Channel, 2017-2030 (US$ Bn)
10.4.3.4. India BCG Vaccine, By Application, 2017-2030 (US$ Bn)
10.4.4. South Korea
10.4.4.1. South Korea BCG Vaccine Market Estimates and Forecast, 2017-2030 (US$ Bn)
10.4.4.2. South Korea BCG Vaccine, By Age Group, 2017-2030 (US$ Bn)
10.4.4.3. South Korea BCG Vaccine, By Distribution Channel, 2017-2030 (US$ Bn)
10.4.4.4. South Korea BCG Vaccine, By Application, 2017-2030 (US$ Bn)
10.4.5. South-East Asia
10.4.5.1. South-East Asia BCG Vaccine Market Estimates and Forecast, 2017-2030 (US$ Bn)
10.4.5.2. South-East Asia BCG Vaccine, By Age Group, 2017-2030 (US$ Bn)
10.4.5.3. South-East Asia BCG Vaccine, By Distribution Channel, 2017-2030 (US$ Bn)
10.4.5.4. South-East Asia BCG Vaccine, By Application, 2017-2030 (US$ Bn)
10.4.6. Rest of Asia Pacific
10.4.6.1. Rest of Asia Pacific BCG Vaccine Market Estimates and Forecast, 2017-2030 (US$ Bn)
10.4.6.2. Rest of Asia Pacific BCG Vaccine, By Age Group, 2017-2030 (US$ Bn)
10.4.6.3. Rest of Asia Pacific BCG Vaccine, By Distribution Channel, 2017-2030 (US$ Bn)
10.4.6.4. Rest of Asia Pacific BCG Vaccine, By Application, 2017-2030 (US$ Bn)

11. Latin America BCG Vaccine Market Analysis
11.1. Latin America BCG Vaccine Market, by Age Group, 2017-2030(US$ Bn)
11.1.1. Overview
11.1.2. SRC Analysis
11.2. Latin America BCG Vaccine Market, by Distribution Channel, 2017-2030(US$ Bn)
11.2.1. Overview
11.2.2. SRC Analysis
11.3. Latin America BCG Vaccine Market, by Application, 2017-2030(US$ Bn)
11.3.1. Overview
11.3.2. SRC Analysis
11.4. Latin America BCG Vaccine Market, by Country, 2017-2030 (US$ Bn)
11.4.1. Brazil
11.4.1.1. Brazil BCG Vaccine Market Estimates and Forecast, 2017-2030 (US$ Bn)
11.4.1.2. Brazil BCG Vaccine, By Age Group, 2017-2030 (US$ Bn)
11.4.1.3. Brazil BCG Vaccine, By Distribution Channel, 2017-2030 (US$ Bn)
11.4.1.4. Brazil BCG Vaccine, By Application, 2017-2030 (US$ Bn)
11.4.2. Mexico
11.4.2.1. Mexico BCG Vaccine Market Estimates and Forecast, 2017-2030 (US$ Bn)
11.4.2.2. Mexico BCG Vaccine, By Age Group, 2017-2030 (US$ Bn)
11.4.2.3. Mexico BCG Vaccine, By Distribution Channel, 2017-2030 (US$ Bn)
11.4.2.4. Mexico BCG Vaccine, By Application, 2017-2030 (US$ Bn)
11.4.3. Rest of Latin America
11.4.3.1. Rest of Latin America BCG Vaccine Market Estimates and Forecast, 2017-2030 (US$ Bn)
11.4.3.2. Rest of Latin America BCG Vaccine, By Age Group, 2017-2030 (US$ Bn)
11.4.3.3. Rest of Latin America BCG Vaccine, By Distribution Channel, 2017-2030 (US$ Bn)
11.4.3.4. Rest of Latin America BCG Vaccine, By Application, 2017-2030 (US$ Bn)

12. Middle East and Africa BCG Vaccine Market Analysis
12.1. Middle East and Africa BCG Vaccine Market, by Age Group, 2017-2030(US$ Bn)
12.1.1. Overview
12.1.2. SRC Analysis
12.2. Middle East and Africa BCG Vaccine Market, by Distribution Channel, 2017-2030(US$ Bn)
12.2.1. Overview
12.2.2. SRC Analysis
12.3. Middle East and Africa BCG Vaccine Market, by Application, 2017-2030(US$ Bn)
12.3.1. Overview
12.3.2. SRC Analysis
12.4. Middle East and Africa BCG Vaccine Market, by Country, 2017-2030 (US$ Bn)
12.4.1. GCC Countries
12.4.1.1. GCC Countries BCG Vaccine Market Estimates and Forecast, 2017-2030 (US$ Bn)
12.4.1.2. GCC Countries BCG Vaccine, By Age Group, 2017-2030 (US$ Bn)
12.4.1.3. GCC Countries BCG Vaccine, By Distribution Channel, 2017-2030 (US$ Bn)
12.4.1.4. GCC Countries BCG Vaccine, By Application, 2017-2030 (US$ Bn)
12.4.2. South Africa
12.4.2.1. South Africa BCG Vaccine Market Estimates and Forecast, 2017-2030 (US$ Bn)
12.4.2.2. South Africa BCG Vaccine, By Age Group, 2017-2030 (US$ Bn)
12.4.2.3. South Africa BCG Vaccine, By Distribution Channel, 2017-2030 (US$ Bn)
12.4.2.4. South Africa BCG Vaccine, By Application, 2017-2030 (US$ Bn)
12.4.3. Rest of Middle East and Africa
12.4.3.1. Rest of Middle East and Africa BCG Vaccine Market Estimates and Forecast, 2017-2030 (US$ Bn)
12.4.3.2. Rest of Middle East and Africa BCG Vaccine, By Age Group, 2017-2030 (US$ Bn)
12.4.3.3. Rest of Middle East and Africa BCG Vaccine, By Distribution Channel, 2017-2030 (US$ Bn)
12.4.3.4. Rest of Middle East and Africa BCG Vaccine, By Application, 2017-2030 (US$ Bn)

13. Company Profiles
13.1. AJ Biologics Sdn Bhd
13.1.1. Company Overview
13.1.2. Products/Services Portfolio
13.1.3. Geographical Presence
13.1.4. Financial Summary
13.1.4.1. Market Revenue and Net Profit (2019-2022)
13.1.4.2. Business Segment Revenue Analysis
13.1.4.3. Geographical Revenue Analysis
13.2. Serum Institute of India Pvt. Ltd.
13.3. GSBPL
13.4. Taj Pharmaceuticals Limited
13.5. Japan BCG Laboratory
13.6. Merck & Co., Inc.
13.7. Microgen
13.8. Biomed Lublin S.A.
13.9. BCG Vaccine Laboratory
13.10. China Biotechnology Co., Ltd.

List of Figures
FIG. 1 Global BCG Vaccine Market: Research Methodology
FIG. 2 Market Size Estimation – Top Down & Bottom up Approach
FIG. 3 Global BCG Vaccine Market Segmentation
FIG. 4 Global BCG Vaccine Market, by Age Group, 2022 (US$ Bn)
FIG. 5 Global BCG Vaccine Market, by Distribution Channel, 2022 (US$ Bn)
FIG. 6 Global BCG Vaccine Market, by Application, 2022 (US$ Bn)
FIG. 7 Global BCG Vaccine Market, by Geography, 2022 (US$ Bn)
FIG. 8 Attractive Investment Proposition, by Age Group, 2022
FIG. 9 Attractive Investment Proposition, by Distribution Channel, 2022
FIG. 10 Attractive Investment Proposition, by Application, 2022
FIG. 11 Attractive Investment Proposition, by Geography, 2022
FIG. 12 Global Market Share Analysis of Key BCG Vaccine Market Manufacturers, 2022
FIG. 13 Global Market Positioning of Key BCG Vaccine Market Manufacturers, 2022
FIG. 14 Global BCG Vaccine Market Value Contribution, By Age Group, 2022 & 2030 (Value %)
FIG. 15 Global BCG Vaccine Market, by Paediatrics, Value, 2017-2030 (US$ Bn)
FIG. 16 Global BCG Vaccine Market, by Adults, Value, 2017-2030 (US$ Bn)
FIG. 17 Global BCG Vaccine Market Value Contribution, By Distribution Channel, 2022 & 2030 (Value %)
FIG. 18 Global BCG Vaccine Market, by Hospitals, Value, 2017-2030 (US$ Bn)
FIG. 19 Global BCG Vaccine Market, by Clinics, 2017-2030 (US$ Bn)
FIG. 20 Global BCG Vaccine Market, by Other Distribution Channels, 2017-2030 (US$ Bn)
FIG. 21 Global BCG Vaccine Market Value Contribution, By Application, 2022 & 2030 (Value %)
FIG. 22 Global BCG Vaccine Market, by Tuberculosis, Value, 2017-2030 (US$ Bn)
FIG. 23 Global BCG Vaccine Market, by Bladder Cancer, 2017-2030 (US$ Bn)
FIG. 24 North America BCG Vaccine Market, 2017-2030 (US$ Bn)
FIG. 25 U.S. BCG Vaccine Market, 2017-2030 (US$ Bn)
FIG. 26 Canada BCG Vaccine Market, 2017-2030 (US$ Bn)
FIG. 27 Europe BCG Vaccine Market, 2017-2030 (US$ Bn)
FIG. 28 Germany BCG Vaccine Market, 2017-2030 (US$ Bn)
FIG. 29 France BCG Vaccine Market, 2017-2030 (US$ Bn)
FIG. 30 U.K. BCG Vaccine Market, 2017-2030 (US$ Bn)
FIG. 31 Italy BCG Vaccine Market, 2017-2030 (US$ Bn)
FIG. 32 Spain BCG Vaccine Market, 2017-2030 (US$ Bn)
FIG. 33 Rest of Europe BCG Vaccine Market, 2017-2030 (US$ Bn)
FIG. 34 Asia Pacific BCG Vaccine Market, 2017-2030 (US$ Bn)
FIG. 35 China BCG Vaccine Market, 2017-2030 (US$ Bn)
FIG. 36 Japan BCG Vaccine Market, 2017-2030 (US$ Bn)
FIG. 37 India BCG Vaccine Market, 2017-2030 (US$ Bn)
FIG. 38 South Korea BCG Vaccine Market, 2017-2030 (US$ Bn)
FIG. 39 South-East Asia BCG Vaccine Market, 2017-2030 (US$ Bn)
FIG. 40 Rest of Asia Pacific BCG Vaccine Market, 2017-2030 (US$ Bn)
FIG. 41 Latin America BCG Vaccine Market, 2017-2030 (US$ Bn)
FIG. 42 Brazil BCG Vaccine Market, 2017-2030 (US$ Bn)
FIG. 43 Mexico BCG Vaccine Market, 2017-2030 (US$ Bn)
FIG. 44 Rest of Latin America BCG Vaccine Market, 2017-2030 (US$ Bn)
FIG. 45 Middle East & Africa BCG Vaccine Market, 2017-2030 (US$ Bn)
FIG. 46 GCC Countries BCG Vaccine Market, 2017-2030 (US$ Bn)
FIG. 47 South Africa BCG Vaccine Market, 2017-2030 (US$ Bn)
FIG. 48 Rest of Middle East and Africa BCG Vaccine Market, 2017-2030 (US$ Bn)

List of Tables
TABLE 1 Market Snapshot: Global BCG Vaccine Market
TABLE 2 Global BCG Vaccine Market, by Competitive Benchmarking, 2022
TABLE 3 Global BCG Vaccine Market, by Geographical Presence Analysis, 2022
TABLE 4 Global BCG Vaccine Market, by Key Strategies Analysis, 2022
TABLE 5 Global BCG Vaccine Market, by Age Group, 2017-2030 (US$ Bn)
TABLE 6 Global BCG Vaccine Market, by Distribution Channel, 2017-2030 (US$ Bn)
TABLE 7 Global BCG Vaccine Market, by Application, 2017-2030 (US$ Bn)
TABLE 8 Global BCG Vaccine Market, by Geography, 2017-2030 (US$ Bn)
TABLE 9 North America BCG Vaccine Market, by Age Group, 2017-2030 (US$ Bn)
TABLE 10 North America BCG Vaccine Market, by Distribution Channel, 2017-2030 (US$ Bn)
TABLE 11 North America BCG Vaccine Market, by Application, 2017-2030 (US$ Bn)
TABLE 12 North America BCG Vaccine Market, by Country, 2017-2030 (US$ Bn)
TABLE 13 US BCG Vaccine Market, by Age Group, 2017-2030 (US$ Bn)
TABLE 14 US BCG Vaccine Market, by Distribution Channel, 2017-2030 (US$ Bn)
TABLE 15 US BCG Vaccine Market, by Application, 2017-2030 (US$ Bn)
TABLE 16 Canada BCG Vaccine Market, by Age Group, 2017-2030 (US$ Bn)
TABLE 17 Canada BCG Vaccine Market, by Distribution Channel, 2017-2030 (US$ Bn)
TABLE 18 Canada BCG Vaccine Market, by Application, 2017-2030 (US$ Bn)
TABLE 19 Europe BCG Vaccine Market, by Age Group, 2017-2030 (US$ Bn)
TABLE 20 Europe BCG Vaccine Market, by Distribution Channel, 2017-2030 (US$ Bn)
TABLE 21 Europe BCG Vaccine Market, by Application, 2017-2030 (US$ Bn)
TABLE 22 Europe BCG Vaccine Market, by Country, 2017-2030 (US$ Bn)
TABLE 23 Germany BCG Vaccine Market, by Age Group, 2017-2030 (US$ Bn)
TABLE 24 Germany BCG Vaccine Market, by Distribution Channel, 2017-2030 (US$ Bn)
TABLE 25 Germany BCG Vaccine Market, by Application, 2017-2030 (US$ Bn)
TABLE 26 France BCG Vaccine Market, by Age Group, 2017-2030 (US$ Bn)
TABLE 27 France BCG Vaccine Market, by Distribution Channel, 2017-2030 (US$ Bn)
TABLE 28 France BCG Vaccine Market, by Application, 2017-2030 (US$ Bn)
TABLE 29 UK BCG Vaccine Market, by Age Group, 2017-2030 (US$ Bn)
TABLE 30 UK BCG Vaccine Market, by Distribution Channel, 2017-2030 (US$ Bn)
TABLE 31 UK BCG Vaccine Market, by Application, 2017-2030 (US$ Bn)
TABLE 32 Italy BCG Vaccine Market, by Age Group, 2017-2030 (US$ Bn)
TABLE 33 Italy BCG Vaccine Market, by Distribution Channel, 2017-2030 (US$ Bn)
TABLE 34 Italy BCG Vaccine Market, by Application, 2017-2030 (US$ Bn)
TABLE 35 Spain BCG Vaccine Market, by Age Group, 2017-2030 (US$ Bn)
TABLE 36 Spain BCG Vaccine Market, by Distribution Channel, 2017-2030 (US$ Bn)
TABLE 37 Spain BCG Vaccine Market, by Application, 2017-2030 (US$ Bn)
TABLE 38 Rest of Europe BCG Vaccine Market, by Age Group, 2017-2030 (US$ Bn)
TABLE 39 Rest of Europe BCG Vaccine Market, by Distribution Channel, 2017-2030 (US$ Bn)
TABLE 40 Rest of Europe BCG Vaccine Market, by Application, 2017-2030 (US$ Bn)
TABLE 41 Asia Pacific BCG Vaccine Market, by Age Group, 2017-2030 (US$ Bn)
TABLE 42 Asia Pacific BCG Vaccine Market, by Distribution Channel, 2017-2030 (US$ Bn)
TABLE 43 Asia Pacific BCG Vaccine Market, by Application, 2017-2030 (US$ Bn)
TABLE 44 Asia Pacific BCG Vaccine Market, by Country, 2017-2030 (US$ Bn)
TABLE 45 China BCG Vaccine Market, by Age Group, 2017-2030 (US$ Bn)
TABLE 46 China BCG Vaccine Market, by Distribution Channel, 2017-2030 (US$ Bn)
TABLE 47 China BCG Vaccine Market, by Application, 2017-2030 (US$ Bn)
TABLE 48 Japan BCG Vaccine Market, by Age Group, 2017-2030 (US$ Bn)
TABLE 49 Japan BCG Vaccine Market, by Distribution Channel, 2017-2030 (US$ Bn)
TABLE 50 Japan BCG Vaccine Market, by Application, 2017-2030 (US$ Bn)
TABLE 51 India BCG Vaccine Market, by Age Group, 2017-2030 (US$ Bn)
TABLE 52 India BCG Vaccine Market, by Distribution Channel, 2017-2030 (US$ Bn)
TABLE 53 India BCG Vaccine Market, by Application, 2017-2030 (US$ Bn)
TABLE 54 South Korea BCG Vaccine Market, by Age Group, 2017-2030 (US$ Bn)
TABLE 55 South Korea BCG Vaccine Market, by Distribution Channel, 2017-2030 (US$ Bn)
TABLE 56 South Korea BCG Vaccine Market, by Application, 2017-2030 (US$ Bn)
TABLE 57 South-East Asia BCG Vaccine Market, by Age Group, 2017-2030 (US$ Bn)
TABLE 58 South-East Asia BCG Vaccine Market, by Distribution Channel, 2017-2030 (US$ Bn)
TABLE 59 South-East Asia BCG Vaccine Market, by Application, 2017-2030 (US$ Bn)
TABLE 60 Rest of Asia Pacific BCG Vaccine Market, by Age Group, 2017-2030 (US$ Bn)
TABLE 61 Rest of Asia Pacific BCG Vaccine Market, by Distribution Channel, 2017-2030 (US$ Bn)
TABLE 62 Rest of Asia Pacific BCG Vaccine Market, by Application, 2017-2030 (US$ Bn)
TABLE 63 Latin America BCG Vaccine Market, by Age Group, 2017-2030 (US$ Bn)
TABLE 64 Latin America BCG Vaccine Market, by Distribution Channel, 2017-2030 (US$ Bn)
TABLE 65 Latin America BCG Vaccine Market, by Application, 2017-2030 (US$ Bn)
TABLE 66 Latin America BCG Vaccine Market, by Country, 2017-2030 (US$ Bn)
TABLE 67 Brazil BCG Vaccine Market, by Age Group, 2017-2030 (US$ Bn)
TABLE 68 Brazil BCG Vaccine Market, by Distribution Channel, 2017-2030 (US$ Bn)
TABLE 69 Brazil BCG Vaccine Market, by Application, 2017-2030 (US$ Bn)
TABLE 70 Mexico BCG Vaccine Market, by Age Group, 2017-2030 (US$ Bn)
TABLE 71 Mexico BCG Vaccine Market, by Distribution Channel, 2017-2030 (US$ Bn)
TABLE 72 Mexico BCG Vaccine Market, by Application, 2017-2030 (US$ Bn)
TABLE 73 Rest of Latin America BCG Vaccine Market, by Age Group, 2017-2030 (US$ Bn)
TABLE 74 Rest of Latin America BCG Vaccine Market, by Distribution Channel, 2017-2030 (US$ Bn)
TABLE 75 Rest of Latin America BCG Vaccine Market, by Application, 2017-2030 (US$ Bn)
TABLE 76 Middle East and Africa BCG Vaccine Market, by Age Group, 2017-2030 (US$ Bn)
TABLE 77 Middle East and Africa BCG Vaccine Market, by Distribution Channel, 2017-2030 (US$ Bn)
TABLE 78 Middle East and Africa BCG Vaccine Market, by Application, 2017-2030 (US$ Bn)
TABLE 79 Middle East and Africa BCG Vaccine Market, by Country, 2017-2030 (US$ Bn)
TABLE 80 GCC Countries BCG Vaccine Market, by Age Group, 2017-2030 (US$ Bn)
TABLE 81 GCC Countries BCG Vaccine Market, by Distribution Channel, 2017-2030 (US$ Bn)
TABLE 82 GCC Countries BCG Vaccine Market, by Application, 2017-2030 (US$ Bn)
TABLE 83 South Africa BCG Vaccine Market, by Age Group, 2017-2030 (US$ Bn)
TABLE 84 South Africa BCG Vaccine Market, by Distribution Channel, 2017-2030 (US$ Bn)
TABLE 85 South Africa BCG Vaccine Market, by Application, 2017-2030 (US$ Bn)
TABLE 86 Rest of Middle East and Africa BCG Vaccine Market, by Age Group, 2017-2030 (US$ Bn)
TABLE 87 Rest of Middle East and Africa BCG Vaccine Market, by Distribution Channel, 2017-2030 (US$ Bn)
TABLE 88 Rest of Middle East and Africa BCG Vaccine Market, by Application, 2017-2030 (US$ Bn)

Frequently Asked Questions:

How does COVID-19 Impact the global BCG vaccine market?

COVID-19 has had a substantial impact on the market due to the outbreak of the COVID-19 pandemic. The BCG vaccine market has seen some revenue. The BCG vaccine is utilized to prevent Tuberculosis (TB), but some researchers have announced that the BCG vaccine can be used for COVID treatment, fuelling the market.

Which is the major region of the market for BCG vaccines?

Asia-Pacific accounted for the most heightened share in the global BCG vaccine market.

What are the key drivers for the growth of the BCG vaccine market?

Increased prevalence of tuberculosis and increasing company initiatives to enhance vaccine R&D drive the global BCG vaccine market.

Which is the major segment in the BCG vaccine market by age group?

The pediatrics segment had a major share in the global market in 2022.

Which is the major segment in the BCG vaccine market by application?

The tuberculosis segment had a major share in the global market.

Purchase Options

Single User

$4699

Multi User

$5699

Custom Report

$7699

Request Free Sample

Have a question?

Don’t settle for less – trust Mitul to help you find the best solution.

Call: +91 6232 49 3207

EMAIL MITUL

Report delivery within 24 to 48 hours

– Other Info –

–What people say?-

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –